Finally, humans are fighting against death, the only mystery hidden till date. A biotech company has planned to conduct a groundbreaking trial on bringing the dead back to life.
Bioquark, a US biotech company, has been granted ethical permission to work on 20 clinically dead patients for testing different methods to bring them back to life. These patients are declared brain-dead and are only kept alive using a life support.
‘Bioquark, a US biotech company, will conduct a medical trial to regenerate the brains of clinically dead people in India.’
The clinical trial is called as ReAnima Project, which has received approval from the National Institutes of Health in the United States.
The patients will be administered with four different types of treatments namely,
- Injecting peptides daily
- Introducing stem cells into the brain twice weekly
- Transcranial laser therapy
- Nerve stimulation
These techniques will be administered for six weeks to help bring people out of the coma. Also, researchers will monitor the patients using brain imaging methods for several months to check for any signs of regeneration especially in the brain stem that controls breathing and heartbeat.
The process will be much similar to salamanders, creatures capable of regrowing their limbs and brains after injury. The trial is the first of its kind and will be conducted at the Anupam Hospital in Rudrapur, Uttarakhand, India.
Dr. Ira Pastor, the company's chief executive, said, "This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime."